Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03975829 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT03975829 · ClinicalTrials.gov record · last posted 2026-08-27

Pediatric Long-Term Follow-up and Rollover Study

Name: Pediatric Long-Term Follow-up and Rollover Study — clinical trial record (NCT03975829)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 4

SponsorNovartis Pharmaceuticals

Started2019-11-04

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.

Protocol amendment history 2 changes detected by DataLookout

2026-06-12

Trial status changed: Recruiting → Active, Not Recruiting

2026-05-06

Trial status changed: Active, Not Recruiting → Recruiting

Trial Details

NCT Number	NCT03975829
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma +15 more
Enrollment	163 participants
Start Date	2019-11-04
Primary Completion	2026-11-05 (estimated)
Study Completion	2026-11-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-27